// App-Quantinova.ai

4838 : Efficacy and Safety of Linezolid in Immunocompromised Patients with Hematological Malignancy

Researchers

Presenter

  • Hua Song

Principal Investigators

  • Xuejin Zhang

  • Xiaohong Zhang

  • Wenji Luo

  • Qian Huang

Medical Centers

  • Department of Hematology, Hangzhou Red Cross Hospital, Hangzhou, China

  • Hematology, Hangzhu No. Peoples Hosp., Hangzhou, China

  • hematology, Xiaoshan No. People's Hospital, hangzhou, China,

  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • Hematology, Children's Hospital affiliated with Zhejiang University, hangzhou, China

  • hematology, Zhejiang Province People's Hospital, hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Multiple Myeloma

  • Thrombocytopenia

  • Aplastic anemia

  • Myelodysplastic Syndrome

  • Lymphomas

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Linezolid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved